Related by context. All words. (Click for frequent words.) 57 myelofibrosis polycythemia vera 57 metastatic neuroendocrine tumors 57 Systemic Lupus Erythematosus SLE 57 myeloproliferative neoplasms 56 myeloproliferative diseases 56 polycythemia vera PV 56 myeloproliferative disorders 56 lymphoid malignancies 56 myelodysplastic myeloproliferative diseases 56 BPH LUTS 56 severe hypercholesterolemia 56 systemic fungal infections 56 activating mutation 55 Dalbavancin 55 allogeneic hematopoietic stem cell 55 myeloproliferative 55 c myb 55 gastrointestinal disorders ATI 55 hypereosinophilic syndrome 55 syndromic 54 benign neoplasms 54 essential thrombocythemia 54 variant allele 54 synthetic analogues 54 gene rearrangements 54 hematologic abnormalities 54 CsA 54 HER2 overexpression 54 recombinant interferon 54 EGFR HER2 54 paragangliomas 54 polycythemia vera essential thrombocythemia 54 papillary renal cell carcinoma 54 TLR antagonist 54 Alequel 53 adverse cytogenetics 53 Accelerated Approval 53 skeletal metastases 53 Cardiotoxicity 53 glycoprotein IIb IIIa inhibitors 53 chronic eosinophilic leukemia 53 Pneumocystis carinii pneumonia 53 clinicopathologic 53 K ras mutations 53 Hematopoietic 53 G CSFs 53 lymphoproliferative disorders 53 Oral BDP 53 inactivating mutations 53 anemias 53 DMEPOS supplier 53 chronic idiopathic thrombocytopenic purpura 53 TLR antagonists 53 AGHD 53 biologic DMARD 53 Xanafide 53 anagrelide 53 ABCB1 53 certolizumab 53 histological subtype 53 Pharmacokinetics PK 53 V#F mutation 53 treat chronic sinusitis 53 tumor lysate 53 sigma receptor 53 Tigecycline 53 vWD 52 mediastinitis 52 leiomyomas 52 TORISEL TM 52 colorectal adenocarcinoma 52 FLT3 52 normal karyotype 52 vertebral compression fracture 52 Ecallantide 52 prokinetic agent 52 osteogenic 52 Vascugel ® 52 NPM1 52 Adenomas 52 Glycosylation 52 epithelial tumors 52 prostate adenocarcinoma 52 MS DRG 52 Bacteremia 52 FluCAM arm 52 tumor necrosis 52 antiplatelet medications 52 essential thrombocythemia ET 52 efalizumab 52 squamous intraepithelial lesions 52 ESBLs 52 primary hyperparathyroidism 52 neoplastic 52 IVDs 52 bronchogenic carcinoma 52 Hedgehog Pathway Inhibitor 52 Epidermal Growth Factor Receptor 52 PGx 52 nosocomial pneumonia NP 52 lipid biosynthesis 52 histone deacetylase HDAC 52 haematological malignancies 52 selective modulator 52 eribulin mesylate 52 renal tumors 52 HES CEL 52 protein tyrosine phosphatases 52 Hurthle cell 52 Chronic Prostatitis 52 Interferon alfa 52 intraepithelial neoplasia 52 immunosuppression therapy 52 preoperative diagnosis 52 renal cysts 52 BPS IC 52 histologies 52 nosocomial pneumonia 52 acetonide FA 52 S aureus 51 Nephrogenic Systemic Fibrosis 51 calcineurin inhibitors 51 SSc 51 neuropsychiatric diseases 51 ß blockers 51 Enterobacteriaceae 51 alemtuzumab MS 51 neoplastic diseases 51 imatinib resistance 51 cefprozil 51 drugable targets 51 hepatorenal syndrome 51 HSCT 51 dyslipidemias 51 extracranial 51 promoter methylation 51 glucocorticoid induced 51 torsade de pointes 51 biliary tract cancer 51 Polymorphisms 51 microdeletion 51 invasive aspergillosis 51 JAK2 inhibitor 51 Shc 51 acute GvHD 51 squamous 51 Apoptotic 51 Infusion Reactions Severe 51 genotypic resistance 51 Tumor Response 51 Percutaneous Coronary Interventions 51 microsatellite instability 51 kidney urologic 51 TMPRSS2 ERG 51 argatroban 51 antimicrobial prophylaxis 51 benzimidazole 51 colorectal liver metastases 51 MTP inhibitor 51 IL 1ß 51 Daptomycin 51 BRCA1 BRCA2 51 antiepileptics 51 delipidation 51 metastatic malignant melanoma 51 FDA Investigational Device 51 immunoregulatory 51 Afatinib 51 pT2 51 rheumatoid arthritis Crohn disease 51 triciribine phosphate monohydrate 51 NF kB pathway 51 TURBT 51 haematopoietic 51 genomic biomarker 51 miRview squamous 51 anti CD# antibodies 51 MGUS 51 tumor histology 51 lamivudine resistant 51 KEGG 51 haematologic 51 generalized vitiligo 51 sunitinib Sutent 51 Warfarin Coumadin 51 gastrointestinal disorders characterized 51 mucinous 51 allogeneic stem cell 51 gastric adenocarcinoma 51 carcinoid tumors 51 pediatric Crohn disease 51 Gorlin syndrome 51 gastric carcinoma 51 latent tuberculosis infection 51 orally administered inhibitor 51 ara C 51 JAK1 51 Fas ligand 51 gastrointestinal stromal tumors GIST 51 acyclovir Lauriad R 51 epidural steroid injection 51 chronic GVHD 51 tumor lysis syndrome 51 renal allograft 51 UPLYSO 51 Catheter Associated 51 Cathepsin B 51 eCTD format 51 allogeneic bone marrow 51 GERD migraine headaches 51 pancreatic neuroendocrine tumors 51 Fibroblast Growth Factor Receptor 51 Adrenergic 51 PrevOnco 51 transthyretin TTR mediated amyloidosis 51 percutaneous vertebroplasty 51 predialysis 50 CYP#C# [002] 50 porcine derived 50 enterococcal 50 follicular thyroid cancer 50 biliary stones 50 vapreotide acetate 50 Diabetic Neuropathy 50 DNA methyltransferases 50 Pafuramidine 50 CMV reactivation 50 interferon IFN 50 idiopathic myelofibrosis 50 cytostatic 50 2 inhibitor CYT# 50 DCVax R 50 myopathy rhabdomyolysis 50 C. difficile toxins 50 Surgical resection 50 obscure gastrointestinal bleeding 50 prognostic biomarker 50 pemphigus 50 Bruton tyrosine kinase 50 Nektar proprietary 50 Liver transplantation 50 rheumatic disorders 50 Idiopathic Pulmonary Fibrosis 50 non nucleoside HCV 50 laparoscopic radical nephrectomy 50 r hGH 50 Trovax 50 neoadjuvant setting 50 Approvable 50 quadrivalent human papillomavirus 50 de novo AML 50 pharmacodynamic parameters 50 Exelixis XL# 50 fosbretabulin 50 Gleevec imatinib mesylate 50 rheumatoid arthritis psoriasis 50 candidiasis 50 Tesmilifene 50 hepatic failure 50 hepatic insufficiency 50 telomerase activators 50 preserved LVEF 50 malignant ascites 50 HBeAg positive patients 50 Progressive Multifocal Leukoencephalopathy 50 Serious Adverse Events 50 immunocompetent 50 thyroid carcinoma 50 kinesin spindle protein KSP 50 Onalta TM 50 fibrinolysis 50 fallopian tube cancers 50 HBeAg negative 50 selective agonists 50 florbetaben 50 Cloretazine VNP#M 50 lymphomas leukemias 50 Histologic 50 Heart Transplant Recipients 50 Golimumab 50 papillary thyroid carcinoma 50 Leukemias 50 Enzastaurin 50 ANN INTERN MED 50 bevacizumab Avastin ® 50 haematopoietic stem cell 50 AFRS TM 50 metastatic RCC 50 PSVT 50 Accelerating apoptosis may 50 arteriovenous fistulas 50 steroid refractory 50 Pegylated Liposomal Doxorubicin 50 independent prognostic marker 50 opioid induced constipation OIC 50 Bcr Abl inhibitors 50 Sezary syndrome 50 Adverse Event 50 non selective NSAIDs 50 urothelial carcinoma 50 antiarrhythmic drug 50 polidocanol 50 pretransplant 50 Marketing Authorization Applications 50 overactive bladder syndrome 50 empiric therapy 50 Actinic Keratosis 50 dasatinib Sprycel ® 50 pituitary adenomas 50 TLIF 50 BCG refractory 50 SinuNase TM 50 Guideline Update 50 antisense inhibitor 50 systemic autoimmune 50 prostate carcinoma 50 solar keratoses 50 NOMID 50 demethylating agent 50 novel VDA molecule 50 topical anti infectives 50 cervicitis 50 MYCAMINE 50 ON #.Na 50 JAK2 enzyme 50 Pyridorin 50 T1DM 50 Portal Hypertension 50 peripheral arterial 50 malignant lymphomas 50 Progenitor cells 50 mutational status 50 Recurrent Glioblastoma 50 Afib 50 Cloretazine 50 Percutaneous Tibial Nerve Stimulation 50 HIV HCV coinfected 50 plasmacytoid 50 SPRYCEL ® 50 protein tyrosine phosphatase 50 Neurodegenerative diseases 50 psoriasis IBD 50 Plaque Psoriasis 50 immunosuppressive therapies 50 Chronic Lymphocytic Leukemia CLL 50 mycosis fungoides 50 Sudhir Agrawal D.Phil 50 basal cell carcinoma BCC 50 daily Glumetza TM 50 haematological 50 myofibroblasts 50 pain palliation 50 vincristine doxorubicin 50 JAK2 V#F 50 G#DT 50 Systemic Sclerosis 50 guideline concordant 50 clefting 50 ALT flares 50 tyrosine kinase inhibitors TKIs 50 BCL#A 50 small molecule activators 50 pulmonary resection 50 Current Procedural Terminology CPT 50 intra abdominal infections 50 relapsed MM 50 hERG 50 somatization disorder 50 follicular lymphoma FL 50 crossclamp 49 p# biomarker 49 candidemia 49 curative therapy 49 Geron telomerase technology 49 ALK inhibitors 49 cytogenetic abnormalities 49 thymoma 49 prolyl 49 percutaneous drainage 49 Anticalin ® 49 meniscectomy 49 extranodal 49 unfavorable cytogenetics 49 Severe Sepsis 49 acyclovir Lauriad ® 49 Sanvar R 49 recurrent DVT 49 Hodgkin lymphoma HL 49 ALN TTR 49 ICD9 49 Tß4 49 ISRCTN# 49 CATANIA TM stent 49 allogeneic transplantation 49 non nucleoside 49 histone deacetylase HDAC inhibitor 49 ribavirin therapy 49 hematological parameters 49 motor neuron degeneration 49 receptor tyrosine kinase inhibitor 49 constipation OIC 49 ZFP TFs 49 tumorigenicity 49 eosinophilic pneumonia 49 CLL SLL 49 Accelerated Partial Breast Irradiation 49 ALN HPN 49 allogeneic hematopoietic cell 49 novel emulsion formulation 49 pertussis toxin 49 treat brain aneurysms 49 recurrent sinusitis 49 ELISPOT 49 metaplasia 49 NMIBC 49 chromosomal rearrangement 49 proliferative disorders 49 treatment naive genotype 49 unresectable recurrent 49 Monoclonal antibody 49 HBeAg + 49 INC# 49 Current Controlled Trials 49 busulfan 49 Common Procedure Coding 49 myelomas 49 heparin induced thrombocytopenia 49 XLIF 49 phototoxicity 49 adenomatous polyps 49 Adefovir 49 Zenvia Phase III 49 generation purine nucleoside 49 Glucocorticoids 49 chemoembolization 49 potent cytotoxic 49 Peyronie Disease 49 Gleevec resistant 49 intracranial hemorrhage ICH 49 BEXXAR Therapeutic Regimen 49 operable breast cancer 49 SIMPONI ® 49 Corgentin 49 Potent Inhibitor 49 muscarinic receptor 49 adjuvant therapies 49 Competent Authorities 49 endoscopic ultrasonography 49 proton MR spectroscopy 49 PREVU x LT 49 Renal Function 49 Onconase 49 cytomegalovirus infection 49 transthoracic 49 antineoplastic 49 Diabetic Foot Ulcer 49 lumbosacral spine 49 capsular polysaccharide 49 Shigamabs 49 Meningiomas 49 pharmacogenetic testing 49 edifoligide E2F Decoy 49 N. gonorrhoeae 49 pulmonary hypertension PH 49 Remicade infliximab 49 monoclonal anti 49 HCV Genotype 49 Epivir HBV 49 osteoporotic vertebral compression fractures 49 cholesteryl ester transfer 49 refractory CLL 49 Acute Coronary Syndromes ACS 49 HBsAg 49 humoral responses 49 neuroendocrine cancers 49 CD4 + CD# 49 transplantation HCT 49 adult chronic ITP 49 mTOR inhibitors 49 Estrogen Receptor 49 MCSP respectively 49 alkylating 49 relapsed ALL 49 biologic DMARDs 49 NMDA antagonists 49 indications contraindications 49 adeno associated viruses 49 antiangiogenic agent 49 colostomy ileostomy 49 CDK inhibitor 49 PC# cells 49 inhibiting viral replication 49 QT Prolongation 49 molecular biomarkers 49 hematopoietic malignancies 49 somatic mutations 49 neurogenic 49 erythropoietic 49 Cytomegalovirus CMV 49 serologic 49 including eniluracil ADH 49 bronchoalveolar lavage BAL 49 TAFA# 49 endothelin receptor antagonists 49 anti androgens 49 intravesical therapy 49 asplenia 49 Nonclinical 49 malignant neoplasms 49 Enkephalin 49 dorsal root ganglion 49 Triapine 49 recurrent NSCLC 49 epigenetic therapies 49 extramedullary 49 Factor VIIa 49 secondary hyperparathyroidism 49 immunomodulatory therapy 49 HepDirect prodrug 49 cytopenias 49 Virologic 49 tropism testing 49 GnRH agonists 49 TÎ ² 4 49 polynucleotide 49 Octreolin 49 daptomycin 49 miRview meso 49 MNTX 49 Bacillus Calmette Guerin BCG 49 pleural fluid 49 histone deacetylase inhibitor 49 riociguat 49 cranial irradiation 49 Antisoma AS# 49 cytokine receptors 49 CMV disease 49 SLNB 49 immunosuppressive agents 49 monoinfected patients 49 antiphospholipid antibodies 49 HGPIN 49 histamine dihydrochloride 49 Tasigna nilotinib 49 interferon lambda 49 selective inhibition 49 RQ PCR 49 anthracycline containing 49 weekly subcutaneous injections 49 cIAI 49 chronic bronchitis AECB 49 CYP #D# 49 somatostatin analogs 49 thalidomide Thalomid 49 refractory chronic lymphocytic 49 gonococcal 49 myelofibrosis MF 49 fusion enhancers 49 tipranavir ritonavir 49 upper aerodigestive tract 49 IGRAs 49 Fibroblast 49 CINTREDEKIN BESUDOTOX 49 Ultrasound Guided 49 metastatic GIST 49 sarcomatoid 49 ISTODAX ® 49 Adult Stem Cell Therapy 49 Mantoux test 49 Investigational Drugs 49 hepatocellular carcinomas 49 depsipeptide 49 Simulect 49 bazedoxifene conjugated estrogens 49 histopathological 49 endometrial biopsies 49 hematopoietic cancers 49 Percutaneous Coronary Intervention 49 UGT#A# 49 Zavesca R 49 Elitek 49 percutaneous ablation 49 antithrombotic agents 49 diagnostic molecular imaging 49 GI motility disorders 49 coronary carotid 49 NPM1 mutation 49 nonalcoholic steatohepatitis NASH 49 temsirolimus Torisel 49 BCR ABL mutations 49 Histological 49 PIDs 49 Renal impairment 49 cell adhesion molecule 49 coagulation assays 49 endobronchial 49 small lymphocytic lymphoma 49 achieved CCyR 49 rheumatologic 49 cytokine signaling 49 Delaying apoptosis may 49 nodal metastasis 49 TNF receptor 49 renoprotective 49 enzyme immunoassay EIA 49 Collategene 49 Chronic HCV 49 baseline LDH 49 CRp 49 Hepatitis B Virus 49 catheter occlusion 49 cancer mCRC 48 hyperoxaluria 48 parenteral antibiotics 48 HBV infections 48 somatic mutation 48 colorectal carcinoma 48 Pseudomonas aeruginosa infections 48 Transcriptional 48 immunomodulation 48 chemosensitivity 48 prospective multicenter study 48 Activating mutations 48 HBV infection 48 refractory GIST 48 perfusion abnormalities 48 mutated K ras 48 transthyretin amyloidosis 48 renal anemia 48 CPT coding 48 endovascular aneurysm repair EVAR 48 gastrointestinal stromal tumors GISTs 48 HSCR 48 HBeAg negative patients 48 ano genital warts 48 histologic subtype 48 NRTI resistance 48 prospectively enrolled 48 Computed Tomographic 48 Bacterin develops employs 48 poor metabolizers 48 Modifiable 48 intravenous tissue plasminogen 48 Bcr Abl mutations 48 pheochromocytoma 48 COL#A# 48 pancreatic enzyme replacement 48 epoetin alpha 48 anaphylactic reactions bronchospasm 48 Vaprisol 48 neuro inflammatory 48 β blockers 48 cerebral vasospasm 48 Nilotinib 48 Contraindications 48 BSIs 48 allograft rejection 48 Arch Intern Med 48 Inhaled AAT 48 CYT# potent vascular disrupting 48 clinico pathological 48 BrachySil TM 48 Faropenem 48 Diastolic Heart Failure 48 allogeneic transplant 48 Thymosin Beta 4 48 Files Investigational 48 transrectal ultrasound guided 48 DXA scan 48 benign prostatic hypertrophy BPH 48 NS5A 48 chloride secretion 48 hoFH 48 Parkinsonian Syndromes 48 Interferon beta 48 allogeneic HSCT 48 Acute Decompensated Heart Failure 48 enzymatic pathways 48 malignant pleural mesothelioma 48 mg administered orally 48 XYOTAX TM 48 Subpart E 48 symptomatic benign prostatic 48 DaTscan 48 acadesine 48 Plasmid DNA 48 recurrent glioblastoma multiforme 48 hepatic metastases 48 immunomodulatory therapies 48 Myelodysplastic syndromes MDS 48 Secretase 48 Interferon Alfa 48 Erlotinib 48 polyarticular 48 CIMZIA TM certolizumab pegol 48 cMET 48 Capsule endoscopy 48 Evoltra ® 48 tumoral 48 Edurant 48 CYP# [001] 48 hyperproliferative 48 subcutaneous immunoglobulin 48 chemotherapy hormonal therapy 48 www.ClinicalTrials.gov 48 familial amyloidotic polyneuropathy FAP 48 solid organ transplantation 48 SIMPONI TM 48 monocytes macrophages 48 Vascugel R 48 VP# [004] 48 etiologic 48 dimeglumine 48 humanized monoclonal antibodies 48 unfavorable prognostic 48 serologic tests 48 osteoporotic compression fractures 48 GIST tumors 48 T2DM 48 intradermal injections 48 Anticalins ® 48 Glycominds 48 metastatic malignant 48 cytogenic 48 Chemokine Receptor 48 Panzem R NCD 48 Romiplostim 48 coagulation disorders 48 germline mutations 48 causative pathogen 48 DNA intercalator 48 oral JAK1 48 % CI #.#-#.# [005] 48 hyperplasia BPH 48 heterologous 48 Myelofibrosis 48 unknown etiology 48 ALCL 48 colorectal carcinomas 48 preclinical efficacy 48 DDP# 48 CRMD 48 mediated autoimmune diseases 48 kidney allograft 48 genetic loci 48 cutaneous melanoma 48 JAK2 gene 48 Neuvenge 48 Kit CD# positive 48 alkylating agents 48 Lenalidomide 48 androgen receptor AR 48 chemokine receptors 48 TOP2A 48 inhibitor RG# 48 Iron Deficiency Anemia 48 Squamous 48 demonstrated antitumor activity 48 chemoprevention trials 48 Fludarabine 48 herpetic keratitis 48 erlotinib Tarceva ® 48 EGFR TKIs 48 VerifyNow P#Y# 48 surgical revascularization 48 mitochondrial toxicity 48 hematopoietic cell 48 Hypotension 48 Glucocorticoid 48 ug dose 48 estrogen receptor beta 48 Lipsovir ® 48 Expedited Review 48 genital tract infections 48 beta lactamase inhibitor 48 MANF 48 norepinephrine transporter 48 menadione 48 TransVax ™ 48 Tyrosine Kinase 48 KRAS gene mutations 48 Cytotoxic T 48 thoracoscopic lobectomy 48 annexin 48 cytotoxicity assays 48 pleiotropic 48 antibiotic prophylaxis 48 sPLA2 48 GH deficiency 48 Artelon ® 48 dosage regimens 48 ISTODAX 48 Removab 48 glucokinase 48 Raptiva ® 48 CB1 antagonists 48 sNDAs 48 Pemetrexed 48 FISH fluorescence 48 FABP 48 rebleeding 48 mediated inhibition 48 c KIT 48 aldosterone antagonists 48 HCV SPRINT 48 coexisting illnesses 48 PDE4 inhibitors 48 G6PD deficiency 48 NOD SCID mice 48 FS Antihemophilic Factor Recombinant 48 Aviptadil 48 iodixanol 48 urine cytology 48 rFVIIa 48 LHRH receptor positive 48 Tyrosine Kinase Inhibitors 48 HBV genotypes 48 nucleic acids proteins 48 Clusterin 48 prucalopride 48 Targretin capsules 48 MGd 48 Acute Renal Failure 48 INFUSE ® 48 KRAS oncogene 48 abnormal p# 48 somatostatin analogues 48 Antiviral Therapy 48 EHT AGN 48 axillary lymph node 48 irinotecan oxaliplatin 48 multicentric 48 Candida infection 48 Prequalified 48 pamidronate 48 chromium picolinate supplementation 48 necrotizing pancreatitis 48 Acute Radiation Syndrome ARS 48 osteoid osteoma 48 immune reconstitution syndrome 48 variceal bleeding 48 FGFR1 48 prostate abnormalities 48 diabetic peripheral neuropathy 48 nephrotoxicity 48 progressive MS SPMS 48 carcinoid syndrome 48 TNF α 48 cardiac repolarization 48 receptor subtypes 48 Cerashield TM 48 tiuxetan 48 rs# [004] 48 immunological diseases 48 Initiate Clinical Trial 48 Oral Fingolimod 48 myeloperoxidase 48 Recombinant interferon alpha 48 radionuclide therapy 48 pelvic lymphadenectomy 48 rheumatoid arthritis gout 48 AV fistula 48 Immunosuppression 48 postexposure prophylaxis 48 ritonavir boosted protease inhibitor 48 MGMT gene 48 Allogeneic 48 3GPP TS #.# 48 Hythiam PROMETA 48 VEGF inhibitors 48 CRVO 48 Circulating tumor cells 48 splice variants 48 diabetes mellitus DM 48 replicon 48 ADVEXIN therapy 48 dermatological disorders 48 extrapulmonary 48 HDAC Inhibitor 48 Chronic Renal Failure 48 macrolide antibiotics 48 pancreatic adenocarcinoma 48 radiculopathy 48 levodopa induced 48 hypersensitivity allergic reactions 48 treating neuropathic pain 48 alpha antagonist 48 bFGF 48 chronic HBV infection 48 multisystemic 48 pharyngitis tonsillitis 48 cystic fibrosis bronchiectasis 48 lymphocytosis 48 Anidulafungin 48 Severe Primary IGFD 48 corticobasal degeneration 48 TP# mutations 48 EGFR tyrosine kinase inhibitors 48 superficial basal cell carcinoma 48 hematological disorders 48 Serious AEs 48 proteasome inhibitor 48 multigenic 48 NTDDS 48 gonococcal infections 48 Coronary Artery Bypass Graft 48 oncological outcomes 48 autologous SCT 48 myomas 48 TNF antagonist 48 ACZ# 48 liver resection 48 psoriatic arthritis PsA 48 Onconova Therapeutics Inc. 48 prostatic hyperplasia 48 trastuzumab Herceptin ® 48 sorafenib Nexavar 48 Civacir 48 quinolone antibiotics 48 MenACWY CRM 48 hematopoietic progenitor cells 48 Bronchiectasis 48 gene loci 48 thromboembolic disease 48 Huntingtons disease 48 underlying vasculopathy 48 Castration Resistant Prostate Cancer 48 von Willebrand 48 MMSEA 48 Fondaparinux 48 licenses bioactive coatings 48 Escherichia coli Klebsiella pneumoniae 48 histocompatibility 48 chain antibody fragment 48 NYSDOH 48 Diffuse Large B 48 multicenter clinical trials 48 IAP inhibitor 48 collagenous colitis 48 ergot alkaloids 48 pulmonary angiography 48 hyper IgE syndrome 48 Venous thromboembolism 48 MAGE A3 ASCI 48 p# inhibitor 48 6 mercaptopurine 48 DCVax ® 48 Voreloxin 48 paraganglioma 48 Protein Kinase C 48 HER2/neu 48 chemotherapy induced neutropenia 48 tonsillar hypertrophy 48 malignant polyps 48 ZOSTAVAX 48 cystic fibrosis chronic pancreatitis 48 systemic fungal infection 48 tigecycline 48 neoplasias 48 OvaRex MAb 48 ARCOXIA 48 Glufosfamide 48 Hematologic 48 Onychomycosis 48 macrolide resistance 48 micafungin 48 myeloid 48 intravenous dosing 48 Vidaza azacitidine 48 drug ISA# 48 NeuroStar TMS Therapy 48 RTIs 48 Notified Bodies 48 T#M mutation 48 SensoLyte ™ 48 systemic lupus erythematosus 48 Combidex 48 Renal Cell Carcinoma RCC 48 severe gastroparesis 48 ERBB2 48 REMINYL ® 48 TNFalpha 48 R#W [002] 48 MDRs 48 CIMYM 48 toxigenic Clostridium difficile 48 thymectomy 48 Lymphoid 48 metastatic dermatofibrosarcoma protuberans DFSP 48 LEAPS H#N# 48 Peregrine bavituximab 48 Arch Surg 48 Antitumor Activity 48 Follicular Lymphoma 48 Non Alcoholic Fatty 48 Intraosseous 48 peptide conjugated 48 nonoperative treatment 48 predictive biomarkers